Prof. Dr. AYŞE ELİF ANIL YAĞCIOĞLU

Yayın Ağı

Makaleler 108

1. The impact of the COVID-19 pandemic on mood symptoms in inpatient mood disorder patients and associated factors

Öz T., OZDEN H. C., YILDIZ M. I., Eroğlu E. Ö., Karahan S., Demir B., et al.

Klinik Psikiyatri Dergisi , cilt.28, sa.3, ss.221-230, 2025 (ESCI, Scopus, TRDizin)

2. Catatonia in autism spectrum disorder: Analysis of clinical characteristics, stressful life events, and validation of the attenuated behavior questionnaire (ABQ)

Oksuzoglu M. E., Rollas T., Erdogan I. M., Aliyev E. S. A., ÜNAL D., KARAHAN S., et al.

PSYCHIATRY RESEARCH , cilt.351, 2025 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

3. Validity and Reliability of the Turkish Adaptation of the Situational Feature Recognition Test-2 in Schizophrenia Patients

Turkoglu O., AVCI H., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI , 2025 (SSCI, Scopus)

4. Differences in clozapine metabolism across geographical regions in Turkiye

MUTLU E., Ozerhan S., Iman M. F., BAYRAKTAR ALKAN İ., YALÇIN N., Demirkan K., et al.

DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES , sa.1, ss.25-32, 2025 (ESCI, Scopus, TRDizin)

5. Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN)

van der Horst M. Z., de Boer N., CLOZIN Collaborators A. E., Okhuijsen-Pfeifer C., Luykx J. J.

SCHIZOPHRENIA , cilt.11, sa.1, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

6. A Case of Pseudotumor Cerebri Associated with Lithium Use

Turkoglu O., Gunes H. N., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI , ss.227-231, 2025 (SSCI, Scopus)

7. Effect of the COVID-19 Pandemic on Psychiatric Service Use Among Psychiatric Outpatients

KILIÇ C., TÜRKOĞLU Ö., AVANOĞLU K. B., ANIL YAĞCIOĞLU A. E., ULUĞ B. D.

TURK PSIKIYATRI DERGISI , ss.237-244, 2024 (SSCI, Scopus)

8. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data

Bennekom M. W. H. L. v., Inthout J., Gijsman H. J., AKDEDE B. B., ANIL YAĞCIOĞLU A. E., Barnes T. R. E., et al.

SCHIZOPHRENIA RESEARCH , cilt.272, ss.1-11, 2024 (SCI-Expanded, SSCI, Scopus)

9. REMISSION AND FOLLOW-UP IN BIPOLAR DEPRESSION WITH ACCELERATED INTERMITTENT THETA BURST STIMULATION PROTOCOL

SİVLİM S., Ozden H. C., ANIL YAĞCIOĞLU A. E., GÜREL Ş. C.

TURK PSIKIYATRI DERGISI , ss.263-265, 2024 (SSCI, Scopus)

10. Investigation of hemorheological parameters in patients with major depressive disorder

Yildiz Y., MUTLU E., Arihan O., ANIL YAĞCIOĞLU A. E., Falkmarken N. H. D.

CLINICAL HEMORHEOLOGY AND MICROCIRCULATION , cilt.87, sa.3, ss.333-345, 2024 (SCI-Expanded, Scopus)

11. A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation.

MUTLU E., ÖZÇELİK EROĞLU E., COŞKUN F. M., KOÇYİĞİT D., CANPOLAT İ. K. N., AVCI H., et al.

Schizophrenia research , cilt.268, ss.138-144, 2024 (SCI-Expanded, SSCI, Scopus)

12. Natural language processing for defining linguistic features in schizophrenia: A sample from Turkish speakers

Çabuk T., Sevim N., MUTLU E., ANIL YAĞCIOĞLU A. E., Koç A., Toulopoulou T.

Schizophrenia Research , cilt.266, ss.183-189, 2024 (SCI-Expanded, SSCI, Scopus)

13. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS)

Vayisoğlu S., KARAHAN S., GÜREL Ş. C., ANIL YAĞCIOĞLU A. E.

Noropsikiyatri Arsivi , cilt.61, sa.1, ss.59-65, 2024 (SCI-Expanded, Scopus, TRDizin)

14. Evaluation of Catatonia with Different Assessment Scales in Psychiatry and Neurology

Erdogan I. M., Aytulun A., Avanoglu K. B., TÜRKOĞLU Ö., Erdogan N. O. K. T. A. R., GÜREL Ş. C., et al.

TURK PSIKIYATRI DERGISI , cilt.35, sa.3, ss.198-206, 2024 (SSCI, Scopus, TRDizin)

15. Catatonia Due to Lithium Neurotoxicity: A Case Report

ALP A., ROLLAS T., Eroglu E. O., Yildiz M. I., ANIL YAĞCIOĞLU A. E., ULUĞ B. D.

TURK PSIKIYATRI DERGISI , cilt.35, sa.2, ss.150-155, 2024 (SSCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

16. Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom.

de Leon J., Arrojo-Romero M., Verdoux H., Ruan C., Schoretsanitis G., Rohde C., et al.

Journal of clinical psychopharmacology , cilt.43, ss.239-245, 2023 (SCI-Expanded, Scopus)

17. Hodgkin Lymphoma in Patients Receiving Clozapine Treatment: 2 Case Reports and Literature Review.

Doǧan M. K., Erdoǧan N. O., ERTUĞRUL A., Yaǧcioǧlu A. E., YAZICI M. S.

Journal of clinical psychopharmacology , cilt.43, sa.2, ss.180-183, 2023 (SCI-Expanded, Scopus)

18. Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition

Schoretsanitis G., ANIL YAĞCIOĞLU A. E., Ruan C., Eap C. B., Molden E., Baptista T., et al.

Schizophrenia Research , 2023 (SCI-Expanded, SSCI, Scopus)

19. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies

Ruan C., Olmos I., Ricciardi C., Schoretsanitis G., Vincent P. D., ANIL YAĞCIOĞLU A. E., et al.

Schizophrenia Research , 2023 (SCI-Expanded, SSCI, Scopus)

20. Effect of clozapine on suicidality in patients with schizophrenia at a university hospital in Turkey

Gürcan G., Şenol Ş. H., Yağcıoğlu A. E., ERTUĞRUL A.

Schizophrenia Research , 2023 (SCI-Expanded, SSCI, Scopus)

21. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series El valproato, la obesidad y otras causas de metabolismo deficiente de la clozapina en el contexto de una titulación rápida de las dosis pueden explicar la miocarditis inducida por clozapina: un nuevo análisis de una serie de casos turca

ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., Ağaoğlu E., Karakaşlı A. A., AK S., YAZICI M. S., et al.

Revista de Psiquiatria y Salud Mental , cilt.15, sa.4, ss.281-286, 2022 (SCI-Expanded, SSCI, Scopus)

22. Şizofreni Bağlamında Psikotik Bozukluklarda Dayanıklılık

MUTLU E., ANIL YAĞCIOĞLU A. E.

Psikiyatride Güncel , cilt.12, sa.4, ss.358-367, 2022 (Hakemli Dergi)

23. An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine

de Leon J., Ruan C., Schoretsanitis G., Rohde C., Yagcioglu E. A., Baptista T., et al.

GENERAL PSYCHIATRY , cilt.35, sa.3, 2022 (ESCI, Scopus)

24. Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users A Systematic Review and A Case Series

Mutlu E., Dogan M. K., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.42, sa.3, ss.298-307, 2022 (SCI-Expanded, SSCI, Scopus)

25. Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders

Okhuijsen-Pfeifer C., van der Horst M. Z., Bousman C. A., Lin B., van Eijk K. R., Ripke S., et al.

TRANSLATIONAL PSYCHIATRY , cilt.12, sa.1, 2022 (SCI-Expanded, Scopus)

26. Renal effects of long-term lithium therapy, revisited

Yazici M. K., Eroglu E. O., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., Agaoglu E., KARAHAN S., et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , cilt.37, sa.2, 2022 (SCI-Expanded, Scopus)

27. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

de Leon J., Schoretsanitis G., Smith R. L., Molden E., Solismaa A., Seppala N., et al.

PHARMACOPSYCHIATRY , cilt.55, sa.02, ss.73-86, 2022 (SCI-Expanded, SSCI, Scopus)

28. Comparison of Formal Thought Disorder in the Acute Episode of Schizophrenia and Manic Episode of Bipolar Affective Disorder

Mutlu E., Gürkan Ş., Göka E., Yağcioğlu A. E.

Turk Psikiyatri Dergisi , cilt.33, sa.4, ss.223-232, 2022 (SSCI, Scopus)

29. Effects of the COVID -19 pandemic on patients with schizophrenia spectrum disorders.

ÖZÇELİK EROĞLU E., ERDOĞAN İ. M., Yıldız M., ANIL YAĞCIOĞLU A. E., TÜRKOĞLU Ö., YALÇINKAYA O. K., et al.

Acta Medica , 2022 (TRDizin)

30. The cognitive aspect of formal thought disorder and its relationship with global social functioning and the quality of life of in schizophrenia

MUTLU E., ABAOĞLU H., BARIŞKIN E., GÜREL Ş. C., ERTUĞRUL A., Yazici M. K., et al.

SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY , cilt.56, ss.1399-1410, 2021 (SCI-Expanded, SSCI, Scopus)

31. Common Side Effects and Metabolic Syndrome due to Clozapine: Relationship with the Clinical Variables and Disability

Gurcan G., Senol S. H., ANIL YAĞCIOĞLU A. E., KARAHAN S., ERTUĞRUL A.

TURK PSIKIYATRI DERGISI , cilt.32, sa.2, ss.87-99, 2021 (SSCI, Scopus, TRDizin)

32. Relapse in patients with serious mental disorders during the COVID-19 outbreak: a retrospective chart review from a community mental health center

Mutlu E., Anil Yagcioglu A. E.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.271, sa.2, ss.381-383, 2021 (SCI-Expanded, Scopus)

33. Augmentation of Clozapine Due to Inadequate Treatment Response in Schizophrenia: Comparison of Patients with Augmented and Non-augmented Treatments

Senol S. H., Gurcan G., ERTUĞRUL A., KARAHAN S., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI , cilt.32, sa.1, ss.1-7, 2021 (SSCI, Scopus, TRDizin)

34. Predictors of discontinuation and hospitalization during long-acting injectable antipsychotic treatment in patients with schizophrenia spectrum disorder

Ucok A., Yagcioglu E. A., AYDIN M., Kara I. A., Erbasan V., TÜRKOĞLU Ö., et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , cilt.36, sa.2, ss.89-96, 2021 (SCI-Expanded, Scopus)

35. Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms.

Gürcan G., Şenol Ş. H., Yağcıoğlu A. E., Ertuğrul A.

Psychiatry research , cilt.296, ss.113665, 2021 (SCI-Expanded, SSCI, Scopus)

36. A follow-up study of metabolic syndrome in schizophrenia

Yoca G., ANIL YAĞCIOĞLU A. E., Eni N., KARAHAN S., TÜRKOĞLU İ., Akal Yıldız E., et al.

European Archives Of Psychiatry And Clinical Neuroscience , cilt.270, ss.611-618, 2020 (SCI-Expanded, Scopus)

37. Weight Loss Associated with Clozapine: A Case Report

Mutlu E., Eroglu E. O., AYHAN Y., Yagcioglu E. A., Yazici M. K.

TURK PSIKIYATRI DERGISI , cilt.31, sa.2, ss.143-145, 2020 (SSCI, Scopus, TRDizin)

38. The Effect of Life Skills Training on Functioning in Schizophrenia: A Randomized Controlled Trial

ABAOĞLU H., Mutlu E., AK S., AKI E., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI , cilt.31, sa.1, ss.50-58, 2020 (SSCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

39. Augmentation of Antipsychotic Treatment with Memantine in Patients with Schizophrenia: A Systematic Review and Meta-Analysis

Vayisoglu S., KARAHAN S., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI , cilt.30, sa.4, ss.253-259, 2019 (SSCI, Scopus, TRDizin)

40. A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoring

ANIL YAĞCIOĞLU A. E., ERTUĞRUL A., KARAKAŞLI A. A., Ağaoğlu E., AK S., KARAHAN S., et al.

Psychiatry Research , cilt.279, ss.90-97, 2019 (SCI-Expanded, SSCI, Scopus)

41. Examination of formal thought disorder and its clinical correlates with the Turkish Version of the Thought and Language Disorder Scale (TALD-TR) in schizophrenia

MUTLU E., YAZICI M. K., BARIŞKIN E., ERTUĞRUL A., GÜREL Ş. C., Gürkan Ş., et al.

Comprehensive Psychiatry , cilt.93, ss.7-13, 2019 (SCI-Expanded, SSCI, Scopus)

42. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia

Ucok A., ANIL YAĞCIOĞLU A. E., Yıldız M., Kaymak Ulusoy S., SAKA M. C., Taşdelen R., et al.

Psychiatry Research , cilt.275, ss.149-154, 2019 (SCI-Expanded, SSCI, Scopus)

43. Ruhsal Bozukluklarda GevşemeEğitiminin Ağrı, Yorgunluk ve Uyku Üzerine Etkisinin İncelenmesi

Kolit Z., EKİCİ ÇAĞLAR G., ANIL YAĞCIOĞLU A. E.

Ergoterapi ve Rehabilitasyon Dergisi , cilt.7, sa.3, ss.171-178, 2019 (TRDizin)

44. Bir Şizofreni Vakasında, Hastalık Sürecinin Erken Döneminde Abilify Maintena® Kullanımı

ANIL YAĞCIOĞLU A. E.

Türkiye Klinikleri , ss.5-6, 2018 (Hakemsiz Dergi)

45. Psikofarmakolojik tedavilerin bilişsel işlevler üzerine etkisi

AYHAN Y., ANIL YAĞCIOĞLU A. E.

Psikiyatride Güncel , cilt.7, 2017 (Hakemli Dergi)

46. Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine

YAGCIOGLU A. E., Yoca G., AYHAN Y., KARACA R. O., Cevik L., MÜDERRİSOĞLU A., et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.36, sa.3, ss.257-261, 2016 (SCI-Expanded, Scopus)

47. VAK A Şizofreni

GÜREL Ş. C., Karabucak B., ANIL YAĞCIOĞLU A. E.

Türkiye Kinikleri , cilt.1, 2015 (Hakemsiz Dergi)

48. Quetiapine Treatment for Self-Mutilation in Chorea-Acanthocytosis A Case Report

AK S., GÜREL Ş. C., Bas D. F., Yagcioglu A. E.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.35, sa.2, ss.208-209, 2015 (SCI-Expanded, Scopus)

49. Prediction of response to antipsychotic drugs in schizophrenia patients within the early phase of treatment

YILDIZ M., YAZICI M. K., ANIL YAĞCIOĞLU A. E., KARAHAN S., Şevik A. E., GÜRSES N.

Bulletin of Clinical Psychopharmacology , cilt.25, ss.390-398, 2015 (SCI-Expanded)

50. Tedaviye Dirençli Şizofrenide Antipsikotikleri Güçlendirme Tedavileri ve Yeni Tedavi Yaklaşımları

GÜREL Ş. C., ANIL YAĞCIOĞLU A. E.

Psikiyatride Güncel , cilt.5, ss.314-329, 2015 (Hakemli Dergi)

51. Quetiapine Treatment for Self Mutilation in Neuroacanthocytosis A Case Report

AK S., GÜREL Ş. C., BAŞ D. F., ANIL YAĞCIOĞLU A. E.

Journal of Clinical Psychopharmacology , cilt.35, ss.208-209, 2015 (SCI-Expanded, Scopus)

52. Augmentation Strategies in Patients with Schizophrenia Who Show Partial Response to Clozapine Treatment

VAYISOĞLU S., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI , cilt.25, sa.3, ss.201-211, 2014 (SSCI, Scopus, TRDizin)

53. A case of clozapine intoxication presenting with atypical NMS symptoms

Kamis G. Z., AYHAN Y., BAŞAR K., ÖZER S., Yagcioglu A. E.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY , cilt.17, sa.5, ss.819-821, 2014 (SCI-Expanded, Scopus)

54. Exome sequence analysis of Finnish patients with clozapine induced agranulocytosis

TİWARİ A., NEED A., LOHOFF F., ZAİ C., CHOWDHURY N., MÜLLER D., et al.

Molecular Psychiatry , cilt.19, ss.403-405, 2014 (SCI-Expanded, Scopus)

55. INVESTIGATION OF THE ROLE OF ALLELIC VARIANTS OF MULTIDRUG RESISTANCE GENE (MDR1) ON CLOZAPINE RELATED LEUKOPENIA/AGRANULOCYTOSIS

ANIL YAĞCIOĞLU A. E., YOCA G., Karaca R. O., ÇEVİK L., BABAOĞLU M. Ö., AYHAN Y., et al.

SCHIZOPHRENIA RESEARCH , cilt.153, 2014 (SCI-Expanded, SSCI, Scopus)

56. Language dependent performance on the letter fluency task in patients with schizophrenia

SUMİYOSHİ C., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., ROY A., JAYATHİLAKE K., MİLBY A., et al.

Schizophrenia Research , cilt.152, ss.421-429, 2014 (SCI-Expanded, SSCI, Scopus)

57. Escitalopram induced Parkinsonism

AK S., ANIL YAĞCIOĞLU A. E.

General Hospital Psychiatry , cilt.36, ss.126, 2014 (SCI-Expanded, SSCI, Scopus)

58. Escitalopram-induced Parkinsonism.

Ak S., Yagcioglu A. E.

General hospital psychiatry , cilt.36, sa.1, 2014 (SCI-Expanded, SSCI, Scopus)

59. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy CADASIL in two siblings with neuropsychiatric symptoms

DERİCİOĞLU N., VURAL A., AGAYEVA N., BAŞAR K., ANIL YAĞCIOĞLU A. E., GÜRSOY ÖZDEMİR Y.

Psychosomatics , cilt.54, ss.594-598, 2013 (SCI-Expanded, SSCI, Scopus)

60. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) in Two Siblings with Neuropsychiatric Symptoms

DERİCİOĞLU N., Vural A., AGAYEYA N., BAŞAR K., YAGCIOGLU A. E., GURSOY-OZDEMIR Y.

PSYCHOSOMATICS , cilt.54, sa.6, ss.594-598, 2013 (SCI-Expanded, SSCI, Scopus)

61. Acute Psychosis and Depression Associated with Hypercalcemia A Case Report

ÖZCAN H., ANIL YAĞCIOĞLU A. E., ŞEVİK A. E., ÜSTÜNDAĞ M. F.

Nöropsikiyatri Arşivi , cilt.50, ss.75-77, 2013 (SCI-Expanded, Scopus, TRDizin)

62. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment

VAYISOĞLU S., ANIL YAĞCIOĞLU A. E., YAĞCIOĞLU S., KARAHAN S., KARCI O., GÜREL Ş. C., et al.

Schizophrneia Research , cilt.143, ss.207-214, 2013 (SCI-Expanded)

63. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment

Vayisoglu S., Yagcioglu A. E., Yagcioglu S., KARAHAN S., Karci O., GÜREL Ş. C., et al.

SCHIZOPHRENIA RESEARCH , cilt.143, sa.1, ss.207-214, 2013 (SCI-Expanded, SSCI, Scopus)

64. LAMOTRIGINE AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA WHO SHOW PARTIAL RESPONSE TO CLOZAPINE TREATMENT

Vayisoglu S., ANIL YAĞCIOĞLU A. E., ANIL YAĞCIOĞLU A. E., KARAHAN S., Karci O., Gurel C., et al.

SCHIZOPHRENIA RESEARCH , cilt.136, 2012 (SCI-Expanded, SSCI, Scopus)

65. Carbamazepine Associated Prolonged Erection in a Patient with Bipolar Disorder

ÖZCAN H., ANIL YAĞCIOĞLU A. E., ŞEVİK A. E., ÜSTÜNDAĞ M. F.

Journal of Mood Disorders , cilt.2, ss.126-128, 2012 (TRDizin)

66. Kardiyovasküler Hastalıklarda Cinsel İşlev Bozukluklarına Psikiyatrik Yaklaşım

YILDIZ İ., ANIL YAĞCIOĞLU A. E.

Türk Kardiyoloji Seminerleri , cilt.12, ss.169-180, 2012 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

67. Neuropsychological Performance and Auditory Event Related Potentials in Schizophrenia Patients and their Siblings A Family Study

ŞEVİK A. E., ANIL YAĞCIOĞLU A. E., YAĞCIOĞLU S., KARAHAN S., GÜRSES N., YILDIZ M.

Schizophrenia Research , cilt.130, ss.195-202, 2011 (SCI-Expanded, SSCI, Scopus)

68. The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey

YAZICI M. S., YAGCIOGLU A. E., ERTUĞRUL A., ENI N., KARAHAN S., KARAAGAOGLU E., et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.261, sa.1, ss.69-78, 2011 (SCI-Expanded, Scopus)

69. Antipsikotiklerin Kardiyak Yan Etkileri

ANIL YAĞCIOĞLU A. E., ERTUĞRUL A.

Psikiyatride Güncel , cilt.1, ss.251-265, 2011 (Hakemli Dergi)

70. Agranulocytosis Related to Clozapine in Monozygotic Twins and Association With Allelic Variants of Multidrug Resistance Gene MDR1

ANIL YAĞCIOĞLU A. E., İLHAN ÇETİN B., GÖKTAŞ M., BABAOĞLU M. Ö., Uz E., YAZICI M. K.

Journal Of Clinical Psychopharmacology , cilt.31, ss.247-249, 2011 (SCI-Expanded, Scopus)

71. Semantic memory deficits based on category fluency performance in schizophrenia: Similar impairment patterns of semantic organization across Turkish and Japanese patients

SUMIYOSHI C., ERTUĞRUL A., Yagcioglu A. E., SUMIYOSHI T.

PSYCHIATRY RESEARCH , cilt.167, ss.47-57, 2009 (SCI-Expanded, SSCI, Scopus)

72. Koroner Yoğun Bakımda Deliriyum

ANIL YAĞCIOĞLU A. E.

Türk Kardiyoloji Seminerleri , cilt.9, ss.85-93, 2009 (Hakemsiz Dergi)

73. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia

Meltzer H. Y., Bobo W. V., Roy A., Jayathilake K., Chen Y., ERTUĞRUL A., et al.

JOURNAL OF CLINICAL PSYCHIATRY , cilt.69, sa.2, ss.274-285, 2008 (SCI-Expanded, SSCI, Scopus)

74. A randomized double blind comparison of clozapine and high doseolanzapine in treatment resistant patients with schizophrenia

MELTZER H. Y., BOBO W., ROY A., JAYATHİLAKE K., CHEN Y., ERTUĞRUL A., et al.

JOURNAL OF CLINICAL PSYCHIATRY , cilt.69, ss.274-285, 2008 (SCI-Expanded, SSCI, Scopus)

75. Antipsikotik ilaçların etki mekanizmaları Şizofreni tedavisinde atipiklik bir üstünlük mü

ANIL YAĞCIOĞLU A. E.

Türk Psikiyatri Dergisi , cilt.18, ss.364-374, 2007 (SSCI, Scopus, TRDizin)

76. [The mechanisms of action of antipsychotic drugs: is atypicality superior in schizophrenia treatment?].

Anil Yağcioğlu A. E.

Turk psikiyatri dergisi = Turkish journal of psychiatry , cilt.18, sa.4, ss.364-74, 2007 (SSCI, Scopus, TRDizin)

77. A double blind study of combination of clozapine with risperidone in patients with schizophrenia effects on cognition

AKDEDE B. B., ANIL YAĞCIOĞLU A. E., ALPTEKİN K., TURGUT T. İ., TÜMÜKLÜ M., YAZICI M. K., et al.

Journal of Clinical Psychiatry , cilt.67, ss.1912-1919, 2006 (SCI-Expanded, SSCI, Scopus)

78. Clozapine alone versus clozapine and risperidone for refractory schizophrenia

Meltzer H., ANIL YAĞCIOĞLU A. E., Akdede B.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.354, sa.17, ss.1846-1847, 2006 (SCI-Expanded, Scopus)

79. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients

Ertugrul A., YAGCIOGLU A. E., ENI N., YAZICI K.

PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.59, sa.2, ss.219-222, 2005 (SCI-Expanded, Scopus)

80. Creutzfeldt Jakob disease A case that initiated with psychiatricsymptoms

KURNE A., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., YAZICI M. K., DEMİRCİ E., KANSU T.

TURK PSIKIYATRI DERGISI , cilt.16, ss.55-59, 2005 (SCI-Expanded, Scopus, TRDizin)

81. Creutzfeldt-Jakob disease: A case that initiated with psychiatric symptoms

KURNE A., Ertugrul A., YAGCIOGLU A. E., DEMIRCI E., YAZICI K., KANSU T.

TURK PSIKIYATRI DERGISI , cilt.16, sa.1, ss.55-59, 2005 (SSCI, Scopus, TRDizin)

82. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety

YAGCIOGLU A. E., AKDEDE B., TURGUT T., TUMUKLU M., YAZICI M., ALPTEKIN K., et al.

JOURNAL OF CLINICAL PSYCHIATRY , cilt.66, sa.1, ss.63-72, 2005 (SCI-Expanded, SSCI, Scopus)

83. Şizofreni Tedavisi ve Antipsikotik İlaçlar

ANIL YAĞCIOĞLU A. E.

Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi , cilt.1, ss.49-56, 2005 (Hakemsiz Dergi)

84. A double blind controlled study of adjunctive treatment with risperidonein schizophrenic patients partially responsive to clozapine Efficacyand safety

ANIL YAĞCIOĞLU A. E., AKDEDE B. B., TURGUT T. İ., TÜMÜKLÜ M., YAZICI M. K., ERTUĞRUL A., et al.

JOURNAL OF CLINICAL PSYCHIATRY , cilt.66, ss.63-72, 2005 (SCI-Expanded, SSCI, Scopus)

85. Venous thromboembolism and escitalopram

KURNE A., Ertugrul A., YAGCIOGLU A. E., YAZICI K.

GENERAL HOSPITAL PSYCHIATRY , cilt.26, sa.6, ss.481-483, 2004 (SCI-Expanded, SSCI, Scopus)

86. A Comparison of Incidence of Diabetes Mellitus Between Atypical Antipsychotic Drugs A Survey for Clozapine Risperidone Olanzapine and Quetiapine

SUMİYOSHİ T., ROY A., ANIL A. E., JAYAHTİLAKE K., ERTUĞRUL A., MELTZER H. Y.

Journal of Clinical Psychopharmacology , cilt.24, ss.345-348, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Severe hyperglycemia associated with electroconvulsive therapy

Dağdelen S., Akın Atmaca A., Gürlek Ö. A., Tufan A., Güven E., Anıl Yağcıoğlu A. E.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.27, ss.615, 2004 (SCI-Expanded, Scopus)

88. A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs - A survey of clozapine, risperidone, olanzapine, and quetiapine

Sumiyoshi T., Roy A., Anil A. E., Jayathilake K., Ertugrul A., Meltzer H.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.24, sa.3, ss.345-348, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

89. A Double Blind Placebo Controlled Cross Over Trial of Adjunctive Donepezil for Cognitive Impairment in Schizophrenia

TUĞAL Ö., YAZICI M. K., ANIL YAĞCIOĞLU A. E., GÖĞÜŞ A.

The International Journal of Neuropsychopharmacology , cilt.7, ss.117-123, 2004 (SCI-Expanded)

90. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

SUMİYOSHİ T., ANIL A. E., JİN D., JAYATHİLAKE K., LEE M., MELTZER H. Y.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY , cilt.7, sa.1, ss.1-8, 2004 (SCI-Expanded, Scopus)

91. Klozapin Kullanımına Bağlı EEG Değişiklikleri

KARATAŞ KURŞUN H., DERİCİOĞLU N., Karabulut E., ANIL YAĞCIOĞLU A. E., Uluşahin A., Ciğer A.

Türk Nöroloji Dergisi , cilt.10, ss.36-42, 2004 (ESCI, Scopus, TRDizin)

92. Re Examination of the Characteristics of the Deficit Schizophrenia Patients

TİRYAKİ A., YAZICI M. K., ANIL A. E., KABAKÇI E., KARAAĞAOĞLU A. E., GÖĞÜŞ A.

European Archives of Psychiatry and Clinical Neuroscience , cilt.253, ss.221-227, 2003 (SCI-Expanded, Scopus)

93. Reexamination of the characteristics of the deficit schizophrenia patients

TIRYAKI A., Yazici M. K., ANIL A. E., KABAKCI E., KARAAGAOGLU E., GOGUS A.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.253, sa.5, ss.221-227, 2003 (SCI-Expanded, Scopus)

94. The Turkish version of the Auditory Consonant Trigram Test as a measure of working memory: A normative study

ANIL A. E., Kivircik B., BATUR S., KABAKÇI E., Kitias A., GÜVEN E., et al.

CLINICAL NEUROPSYCHOLOGIST , cilt.17, sa.2, ss.159-169, 2003 (SCI-Expanded, SSCI, Scopus)

95. Venous Thromboembolism and Clozapine An Association Unresolved

ANIL A. E., ÖZKAN B., ULUŞAHİN A.

General Hospital Psychiatry , cilt.25, ss.59-60, 2003 (SCI-Expanded, SSCI, Scopus)

96. The characteristics, treatment response, safety, and concominant medication use of patients receiving clozapine treatment

Anil A. E., Turgut I., Kabakci E., Rezaki M., Gogus A.

EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.12, 2002 (SCI-Expanded, Scopus)

97. Is deficit syndrome a separate disease within the syndrome of schizophrenia?

Yazici K., Tiryaki A., Anil A. E., Kabakci E., Godup A.

EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.12, 2002 (SCI-Expanded, Scopus)

98. [A review on augmentation of clozapine treatment].

Anil A. E., Turgut I. T., Rezaki M., Göğüş A.

Turk psikiyatri dergisi = Turkish journal of psychiatry , cilt.13, sa.1, ss.65-77, 2002 (SCI-Expanded, TRDizin)

99. Atipik Antipsikotiklere Bağlı Glukoz Metabolizması Bozuklukları

ANIL A. E., MELTZER H. Y.

Türk Psikiyatri Dergisi , cilt.12, ss.225-232, 2001 (SSCI, TRDizin)

100. Şizofrenik Hastalarda Olanzapin ve Klorpromazinin Etki ve Güvenliğinin Karşılaştırılması

KOSTAKOĞLU ., ALPTEKİN K., KIVIRCIK B. B., KABAKÇI E., TUNCA Z., GÖĞÜŞ A.

Türk Psikiyatri Dergisi , cilt.12, ss.3-16, 2001 (SSCI, TRDizin)

101. Response Negative Symptoms Redux

KOSTAKOGLU ., Meltzer H. Y.

Neuropsychopharmacology , cilt.22, ss.662-664, 2000 (SCI-Expanded, SSCI, Scopus)

102. Combining Antipsychotics Is There Evidence for Efficacy

MELTZER H. Y., KOSTAKOĞLU A. E.

Psychiatric Times , cilt.17, ss.25-34, 2000 (Scopus)

103. Yeni Kuşak Antidepresanlar

ANIL A. E., YAZICI M. K.

Hacettepe Tıp Dergisi , cilt.31, ss.353-361, 2000 (Hakemsiz Dergi)

104. Reliability and Validity of the Turkish version of the Positive and Negative Syndrome Scale Pozitif ve Negatif Sendrom Ölçeğinin PANSS Türkçe Uyarlamasının Geçerlik ve Güvenilirliği

KOSTAKOĞLU A. E., BATUR S., TİRYAKİ A., GÖĞÜŞ A.

Türk Psikoloji Dergisi , cilt.14, ss.23-34, 1999 (SSCI)

105. Reliability and validity of the Turkish version of the Positive and Negative Syndrome Scale (PANSS)

Kostakoglu E., Batur S., Tiryaki A., Gogus A.

TURK PSIKOLOJI DERGISI , cilt.14, sa.44, ss.23-34, 1999 (SSCI)

106. Early relapse of psychotic symptoms after an initial response to olanzapine

KOSTAKOĞLU A. E., REZAKİ M., GÖĞÜŞ A.

ACTA PSYCHIATRICA SCANDINAVICA , cilt.100, sa.4, ss.312-314, 1999 (SCI-Expanded, SSCI, Scopus)

107. Negative Symptoms An Overview of the Concept and Response to Antipsychotic Drug Treatment

KOSTAKOĞLU A. E., MELTZER H. Y.

Türkiye’de Psikiyatri , cilt.1, ss.59-71, 1999 (Hakemli Dergi)

108. Ketoacidosis as a side effect of clozapine A case report

KOSTAKOĞLU A. E., YAZICI M. K., ERBAŞ A. T., GÜVENER DEMİRAĞ H. N.

ACTA PSYCHİATRİCA SCANDİNAVİCA , cilt.93, ss.217-218, 1998 (SCI-Expanded, SSCI, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 21

1. Lityum İntoksikasyonunu Takiben Gelişen Amisülpirid Kullanımı ile Ortaya Çıkan Nöroleptik Malign Sendrom: Olgu Sunumu ve Gözden Geçirme.

ALP A., ÖZÇELİK EROĞLU E., ANIL YAĞCIOĞLU A. E.

59. Ulusal Psikiyatri Kongresi, Türkiye, 18 - 22 Ekim 2023, (Özet Bildiri)

2. Klozapinin Optimal Kullanımı: Zorunlu Kesme Sonrası Klozapini Yeniden Başlama ve Klozapin Tedavisine Direnç

ANIL YAĞCIOĞLU A. E.

59. Ulusal Psikiyatri Kongresi, Türkiye, 18 - 22 Ekim 2023, (Özet Bildiri)

3. Şizofreni Hastaları ve Yakınlarına Yönelik Psikoeğitim Programının Hastalık Şiddeti, Tedavi Uyumu, Hastalığa Dair İçgörü, İçselleştirilmiş Damgalanma ve İşlevsellik Üzerine Etkileri.

TÜRKOĞLU Ö., KARAÇAM M., BAKİ H. E., Özden H., Öz T., Gülşen G., et al.

59. Ulusal Psikiyatri Kongresi, 18 Ekim 2023, (Özet Bildiri)

4. Remission/response with esketamine nasal spray versus quetiapine extended release in treatment resistant depression using the Patient Health Questionnaire

YOUNG A., FREY R., NİELSEN R., ANIL YAĞCIOĞLU A. E., Häggström L., Llorca P., et al.

36th. ECNP Congress, Barcelona, İspanya, 07 Ekim 2023, (Özet Bildiri)

5. Esketamine nasal spray shows higher remission and response rates over 32 weeks of treatment compared with quetiapine extended-release in patients with treatment resistant depression: Results from ESCAPE-TRD, a randomized, phase IIIb clinical trial.

Reif A., ANIL YAĞCIOĞLU A. E., Luts A., Messer T., Nielsen R., Buyze J., et al.

31st European Congress of Psychiatry (EPA), Paris, Fransa, 25 Mart 2023, (Özet Bildiri)

6. Catatonia due to a General Medical Condition: Presentation and Review.

Carroll B., Slavnic B., Vellanki K., ANIL YAĞCIOĞLU A. E., ERDOĞAN İ. M., YAZICI M. K.

Psychiatry Update Winter 2023, Amerika Birleşik Devletleri, 01 Şubat 2023, cilt.35, ss.9-10, (Özet Bildiri)

7. Clozapine and Long-Acting Injectable Antipsychotic Combination: A Retrospective Chart Review.

MUTLU E., KARAÇAM M., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.

the 2022 Congress of the Schizophrenia International Research Society (SIRS), İtalya, 06 Nisan 2022, (Özet Bildiri)

8. Klozapinin uzun etkili enjekte edilebilir antipsikotiklerle kombinasyonu

MUTLU E., KARAÇAM M., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E.

57. Ulusal Psikiyatri Kongresi, 20 Ekim 2021, (Özet Bildiri)

9. Yeni Bir Hedef: TAAR1 Eser Amin İlişkili Reseptörler (Trace Amine Associated Receptors)

ANIL YAĞCIOĞLU A. E.

57. Ulusal Psikiyatri Kongresi, Ankara, Türkiye, 20 - 24 Ekim 2021, (Özet Bildiri)

10. Effect of clozapine on suicidality in patients with schizophrenia.

GÜRCAN G., Hun Şenol Ş., ANIL YAĞCIOĞLU A. E., ERTUĞRUL A.

34th ECNP Congress, Lizbon, Portekiz, 02 Ekim 2021, (Özet Bildiri)

11. Perceived ageism, anxiety and depression during the COVİD-19 Pandemic among older patients with mental disorders:a tele-survey

AYTULUN A., ERDEN AKİ Ş. Ö., ANIL YAĞCIOĞLU A. E.

Turkish Association for Psychopharmacology International Update Symposium 2021, Antalya, Türkiye, 10 Nisan 2021, ss.101-102, (Özet Bildiri)

12. Effects of the COVID-19 pandemic on patients with schizophrenia spectrum disorders

ÖZÇELİK EROĞLU E., YILDIZ M. İ., ANIL YAĞCIOĞLU A. E., TÜRKOĞLU Ö., YALÇINKAYA O. K., ERTUĞRUL A., et al.

Turkish Association for Psychopharmacology International Update Symposium 2021, Antalya, Türkiye, 10 Nisan 2021, (Özet Bildiri)

13. Covid-19 Salgınında Ciddi Ruhsal Bozukluğu Olan Hastaların Relaps Oranı – Bir Toplum Ruh Sağlığı Merkezinin İzlem Verileri

MUTLU E., ANIL YAĞCIOĞLU A. E.

56. Ulusal Psikiyatri Kongresi, Türkiye, 18 - 20 Aralık 2020, (Özet Bildiri)

14. Dünyada ve Türkiye’de şizofreni tedavi kılavuzları: Tedaviye direnç

ANIL YAĞCIOĞLU A. E.

56. Ulusal Psikiyatri Kongresi, Türkiye, 18 - 20 Aralık 2020, (Özet Bildiri)

15. The relation of fromal thought disorder with cognitive functions, global and social functioninf and quality of life in patients with schizophrenia

MUTLU E., ABAOĞLU H., BARIŞKIN E., AKI E., ANIL YAĞCIOĞLU A. E., YAZICI M. K.

2020 Congress of the Schizophrenia International Research Society, 4 - 08 Nisan 2020, (Özet Bildiri)

16. PSİKİYATRiK BOZUKLUKLARIN SAPTANMASININ ARDINDAN GEÇ TANI KONULAN BiR DİGEORGE SENDROMU VAKASI

TÜRKOĞLU Ö., ÖZÇELİK EROĞLU E., YILDIZ M. İ., ANIL YAĞCIOĞLU A. E.

55. Ulusal Psikiyatri Kongresi, İstanbul, Türkiye, 23 - 27 Ekim 2019, cilt.30, ss.73, (Özet Bildiri)

17. Şizofrenide Ufuktaki Yeni İlaçlar

ANIL YAĞCIOĞLU A. E.

55. Ulusal Psikiyatri Kongresi, Türkiye, 23 - 27 Ekim 2019, (Özet Bildiri)

18. Şizofrenide Ruhsal Eğitim, Dünya’xxdan ve Türkiye’xxden Örnekler

ANIL YAĞCIOĞLU A. E.

55. Ulusal Pskiyatri Kongresi, Türkiye, 23 - 27 Ekim 2019, (Özet Bildiri)

19. Arilai: a naturalistic open-label study of aripiprazole long acting injectable efficacy on functioning and quality of life in schizophrenia patients

ALPTEKİN K., ANIL YAĞCIOĞLU A. E., EKER S. S., Yıldız M., Kaymak Ulusoy S., TAMAM L., et al.

32nd ECNP, Kopenhag, Danimarka, 7 - 19 Eylül 2019, (Özet Bildiri)

20. Şizofreninin ilaç tedavisinde beklenen yenilikler

ANIL YAĞCIOĞLU A. E.

International Congress on Society and Schizophrenia, Federation of Schizophrenia Associations, 29 - 30 Haziran 2019, (Özet Bildiri)

21. Combination of electroconvulsive therapy and benzodiazepines in an obsessive-compulsive disorder case presenting with catatonia and autistic-like features.

KARAKUŞ Y., YILDIZ M. İ., ANIL YAĞCIOĞLU A. E., KILIÇ C.

11th International Congress on Psychopharmacology 7th International Symposium ın Child and Adolescent Psychopharmacology, Psychiatry and Clinical Psychopharmacology, 18 - 21 Nisan 2019, (Özet Bildiri)

Kitaplar 14

Bilirkişi Raporları 1

1. Information processing abnormalities in schziophrenia and bipolar disorder

ANIL YAĞCIOĞLU A. E.

2018

Metrikler

Yayın

183

Yayın (WoS)

105

Yayın (Scopus)

Atıf (WoS)

1121

H-İndeks (WoS)

Atıf (Scopus)

1012

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)